Recurrent hope for the treatment of preterm delivery

Expert Opinion on Pharmacotherapy

Volumn 4, Issue 12, 2003, Pages 2363-2366

  Doggrell, Sheila A ^a  

^a Doggrell Biomedical Communications   (New Zealand)

Author keywords

17 progesterone caproate; Preterm delivery

Indexed keywords

17-ALPHA-HYDROXY-PROGESTERONE CAPROATE; ANTIINFECTIVE AGENT; ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLINDAMYCIN; ERYTHROMYCIN; HYDROXYPROGESTERONE CAPROATE; INDOMETACIN; METRONIDAZOLE; PLACEBO; PROGESTERONE; PROGESTERONE DERIVATIVE; UTERUS SPASMOLYTIC AGENT;

ARTICLE; BIRTH WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DOSE RESPONSE; DRUG MECHANISM; FEMALE; GESTATION PERIOD; HUMAN; INFANT MORTALITY; INJECTION SITE; MAJOR CLINICAL STUDY; META ANALYSIS; NEGRO; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE LABOR; PRENATAL CARE; RACE DIFFERENCE; RECURRENT ABORTION; RISK ASSESSMENT; RISK FACTOR; SKIN MANIFESTATION; SPONTANEOUS ABORTION; STILLBIRTH; TREATMENT OUTCOME; VAGINITIS;

ABORTION, HABITUAL; ANTI-BACTERIAL AGENTS; CLINICAL TRIALS; FEMALE; HUMANS; HYDROXYPROGESTERONES; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY OUTCOME; RISK FACTORS; TREATMENT OUTCOME;

EID: 0346366722     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.4.12.2363     Document Type: Article

References (15)

1. MEIS JM, KLEBANOFF M, THOM E et al.: Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate: N. Engl, J. Med. (2003) 348:2379-2385.
2. PANETH NS: The problem of low birth rate. Future Child. (1995) 5:19-34.
3. MATTISON DR, DAMUS K, FIORE E, PETRINI J, ALTER C: Preterm delivery: a public health prospective. Paediatr. Perinat. Epidemiol. (2001) 15(Suppl. 2):7-16.
4. GREENE MF: Progesterone and preterm delivery - déjà vu all over again. N. Engl. J. Med. (2003) 384:2453-2455.
5. GYETVAI K, HANNAH ME, HODNETT ED, OHLSSON A. Tocolytics for preterm labor: a systematic review. Obstet. Gynecol. (1999) 94:869-877.
6. CREASY RK: Preterm birth prevention: where are we? Am. J. Obstet. Gynecol. (1993) 168:1223-1230.
7. JOHNSON JWC, AUSTIN KL, JONES GS, DAVIS GH, KING TM: Efficacy of 17α-hydroxyprogesterone caproate in the prevention of premature labor. N. Engl. J. Med. (1975) 293:675-680.
8. YEMINI M, BORENSTEIN R, DREAZEN E et al.: Prevention of premature labor by l7alpha-hydroxyprogesterone caproate. Am. J. Obstet. Gynecol. (1985) 151:574-577.
9. HAUTH JC, GILSTRAP LC 3rd, BREKKEN AL, HAUTH JM: The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population. Am. J. Obstet. Gynecol. (1983) 146:187-190.
10. HARTIKAINEN-SORRI A-L, KAUPPILA A, TUIMALA R: Inefficacy of 17α-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy. Obstet. Gynecol. (1980) 56:692-695.
11. KEIRSE MJ: Progesterone administration in pregnancy may prevent preterm delivery. Br. J. Obstet. Gynaecol. (1990) 97:149-154.
12. GOLSTEIN P, BERRIER J, ROSEN S, SACKS HS, CHALMERS TC: A meta-analysis of randomized control trials of progestational agents in pregnancy. Br. J. Obstet. Gynecol. (1989) 96:265-274.
13. ANDREWS WW, SIBAI BM, THOM EA et al.: Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet. Gynecol. (2003) 101:847-855.
14. UGWUMADU A, MANYONDA I, REID F, HAY P: Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet (2003) 361:983-988.
15. DA FONSECA EB, BITTAR RE, CARVALHO MH, ZUGAIB M: Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women in increased risk: a randomised placebo-controlled doubled-blind study. Am. J. Obstet. Gynecol. (2003) 188:419-424.